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SUMMARY
This thesis is composed of seven articles dealing with se-
veral diagnostic and therapeutic aspects of bone tumors.
Osteosarcoma and malignant f ibrous histiocytoma
(MFH) of bone received special attention. These two ma-
lignant primary bone tumors have grade of malignancy,
predeliction side, and sensitivity to chemotherapy com-
mon. As a consequence there are no essential differences in
treatment.
Chapter II
Complications of bone biopsies proved rare in a series of
206 bone biopsies performed over a period of 42 months.
There were no serious complications with a negative effect
on the ultimate course of the disease. Fractures did occur in
patients receiving chemotherapy; precisely in this group
this possibil i ty should be borne in mind. As expected, open
biopsies produced adequate material more often (98%)
than did dri l l  biopsies (70%). The choice between the two
techniques, however, depends on individual factors.
Chapter III
Once chemotherapy is started it is very important to ob-
tain information on the response of the primary tumor to
this treatment, because the principle is that continuation of
chemotherapy is not justif iable in the case of tumor pro-
gression, when the primary tumor should be resected as
soon as possible. Simple conventional X-rays continue to
be a useful aid within the range of evaluation methods.
Chapter IY
Malignant f ibrous histiocytoma of bone is a tumor first
defined as a separate entity in 1972. Little was known about
the primary treatment of choice of this tumor, which at that
time was usually classified with the osteosarcomas or f ibro-
sarcomas. Seven patients were treated in Groningen be-
tween 1977 and 1985 ; f ive were given chemotherapy in ad-
dition to surgery. Two of these five were treated by primary
amputation and survived with a follow-up of 58 and 30
months respectively after diagnosis. The remaining three
patients first received chemotherapy, and the tumor re-
sponse was histologically verif iable. All three showed a
complete tumor response (no more viable tumor tissue)
and survived with a follow-up of 56, 46 and 25 months re-
spectively after diagnosis. In view of the far less favorable
historical survival data (not different from those for oste-
osarcoma or fibrosarcoma), primary chemotherapy seems
the t reatment  of  choice.
Chapter V
Thirty-two patients with an osteosarcoma of the lower
extremity (the site of predilection for osteosarcoma) were
treated between July 1977 and July 1985. Treatment con-
sisted of a combination of chemotherapy (32 patients) and
surgery (29 patients). Nine patients showed metastases at
the time of diagnosis. Only one of them died with a follow-
up of 62 months after diagnosis. The remaining eight all
died within 18 months. Of the 23 patients without metasta-
ses at the time of diagnosis, f ive were for various reasons
treated by primary amputation followed by chemotherapy
(including high dose methotrexate, HDMTX). All f ive sur-
vived with a mean follow-up of 76 months. The other 18 pa-
tients received chemotherapy prior to surgery. Two of
them died: one from chemotherapy complications and the
other from metastases. The two-year survival in the entire
group of patients without metastases at diagnosis was91"Á
(21123). The survival in the group available for a five-year
follow-up was 85% ( 1 1/13). In nine of the 26 patients (35% )
with a tumor in the femur surgery comprised local resection
and reconstruction using an endoprosthesis. All survived
with a mean follow-up of 69 (99-20) months. Our study
shows that chemotherapy greatly improves the survival of
patients with an osteosarcoma of the lower extremity. In
selected cases l imb salvage surgery was found to be feasi-
b le.
Chapter VI
From the total group of patients with malignant bone tu-
mors (osteosarcoma, chondrosarcoma and malignant f i-
brous histiocytome of bone) 15 were selected for local re-
section and reconstruction with the aid of an endoprosthe-
sis. In the end, endoprostheses were implanted in 12 pa-
tients. The results of l imb salvage operations were satisfac-
tory in this group. The advantages and disadvantages ofthe
endoprosthesis and the complicatins of this therapy in this
group of young patients are discussed.
Chapter VII
The literature indicates that both radiotherapy and che-
motherapy may weaken bone. In the group of patients with
a femoral osteosarcoma treated by chemotherapy, local tu-
mor resection and reconstruction using an endoprosthesis,
two sustained a total of four epiphyseal fractures floowing a
minimal injury. Careful radiological analysis suggests that
the localization is to be sought mainly in the metaphysis.




In order to gain more insight into the biomechanical
aspects of segmental femur resections and reconstructions
using an endoprosthesis a mathematical model was used to
obtain general information on the most frequently perfor-
med femur resections.
Apart from the design data required for a 'unit construc-
tion set' endoprosthesis as presented in a thesis by Dr. F.
M. van Krieken, it was found that no adequate effect can be
expected from muscle transplantations with changed mus-
cle insertion sites in order to strengthen a muscle group in-
jured as a result of a tumor excision.
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